US State-Level Legal Interventions Related to COVID-19 Vaccine Mandates

This study assesses state-level legal interventions to promote or impede COVID-19 vaccine mandates in the US since the beginning of the pandemic

Liquid Phase Hydrodechlorination of Dieldrin and DDT over Pd/C and Raney-Ni

Selectivity and product distribution of hydrodechlorination (HDCl) of dieldrin and DDT are studied in different liquid phase systems, namely in: (1) in ethanol; and (2) in the supported ionic liquid heterogeneous catalytic system (multiphase system), composed by the organic phase and aqueous KOH, a quaternary ammonium ionic liquid promoter (Aliquat 336), and a metal catalyst, e.g. 5% Pd/C, 5% Pt/C, or Raney-Ni. At 50 8C and atmospheric pressure of hydrogen, a quantitative hydrodechlorination of DDT in the biphasic system with ionic liquid layer is achieved in 40 min and in 4 h with Raney-Ni and Pd/C, respectively, while the reaction on Pt/C or on Pd/C without Aliquat 336 is slow. Dieldrin undergoes partial dechlorination, with high selectivity achievable only for its mono- and bi-dechlorination products. Dechlorination pathways and reactivity of different types of organic chlorine atoms versus the catalyst nature and other conditions are discussed

Jazz Guitar Ensemble and Jazz Combos

Kennesaw State University School of Music presents Jazz Guitar Ensemble and Jazz Combos.https://digitalcommons.kennesaw.edu/musicprograms/1353/thumbnail.jp

Jazz Guitar Ensemble and Jazz Combos

Kennesaw State University School of Music presents Jazz Guitar Ensemble and Jazz Combos.https://digitalcommons.kennesaw.edu/musicprograms/1422/thumbnail.jp

Mixed Chamber Ensembles

KSU School of Music presents Mixed Chamber Ensembles.https://digitalcommons.kennesaw.edu/musicprograms/1312/thumbnail.jp

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine

Despite rapid technical progress and demonstrable effectiveness for some types of diagnosis and therapy, much remains to be learned about clinical genome and exome sequencing (CGES) and its role within the practice of medicine. The Clinical Sequencing Exploratory Research (CSER) consortium includes 18 extramural research projects, one National Human Genome Research Institute (NHGRI) intramural project, and a coordinating center funded by the NHGRI and National Cancer Institute. The consortium is exploring analytic and clinical validity and utility, as well as the ethical, legal, and social implications of sequencing via multidisciplinary approaches; it has thus far recruited 5,577 participants across a spectrum of symptomatic and healthy children and adults by utilizing both germline and cancer sequencing. The CSER consortium is analyzing data and creating publically available procedures and tools related to participant preferences and consent, variant classification, disclosure and management of primary and secondary findings, health outcomes, and integration with electronic health records. Future research directions will refine measures of clinical utility of CGES in both germline and somatic testing, evaluate the use of CGES for screening in healthy individuals, explore the penetrance of pathogenic variants through extensive phenotyping, reduce discordances in public databases of genes and variants, examine social and ethnic disparities in the provision of genomics services, explore regulatory issues, and estimate the value and downstream costs of sequencing. The CSER consortium has established a shared community of research sites by using diverse approaches to pursue the evidence-based development of best practices in genomic medicine

Validation of a novel multivariate method of defining HIV-associated cognitive impairment

Background. The optimum method of defining cognitive impairment in virally suppressed people living with HIV is unknown. We evaluated the relationships between cognitive impairment, including using a novel multivariate method (NMM), patient– reported outcome measures (PROMs), and neuroimaging markers of brain structure across 3 cohorts. Methods. Differences in the prevalence of cognitive impairment, PROMs, and neuroimaging data from the COBRA, CHARTER, and POPPY cohorts (total n = 908) were determined between HIV-positive participants with and without cognitive impairment defined using the HIV-associated neurocognitive disorders (HAND), global deficit score (GDS), and NMM criteria. Results. The prevalence of cognitive impairment varied by up to 27% between methods used to define impairment (eg, 48% for HAND vs 21% for NMM in the CHARTER study). Associations between objective cognitive impairment and subjective cognitive complaints generally were weak. Physical and mental health summary scores (SF-36) were lowest for NMM-defined impairment (P < .05). There were no differences in brain volumes or cortical thickness between participants with and without cognitive impairment defined using the HAND and GDS measures. In contrast, those identified with cognitive impairment by the NMM had reduced mean cortical thickness in both hemispheres (P < .05), as well as smaller brain volumes (P < .01). The associations with measures of white matter microstructure and brain-predicted age generally were weaker. Conclusion. Different methods of defining cognitive impairment identify different people with varying symptomatology and measures of brain injury. Overall, NMM-defined impairment was associated with most neuroimaging abnormalities and poorer selfreported health status. This may be due to the statistical advantage of using a multivariate approac

Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand.

Background: Data on durability of first-line antiretroviral therapy (ART) in children with human immunodeficiency virus (HIV) are limited. We assessed time to switch to second-line therapy in 16 European countries and Thailand. Methods: Children aged <18 years initiating combination ART (≥2 nucleoside reverse transcriptase inhibitors [NRTIs] plus nonnucleoside reverse transcriptase inhibitor [NNRTI] or boosted protease inhibitor [PI]) were included. Switch to second-line was defined as (i) change across drug class (PI to NNRTI or vice versa) or within PI class plus change of ≥1 NRTI; (ii) change from single to dual PI; or (iii) addition of a new drug class. Cumulative incidence of switch was calculated with death and loss to follow-up as competing risks. Results: Of 3668 children included, median age at ART initiation was 6.1 (interquartile range (IQR), 1.7-10.5) years. Initial regimens were 32% PI based, 34% nevirapine (NVP) based, and 33% efavirenz based. Median duration of follow-up was 5.4 (IQR, 2.9-8.3) years. Cumulative incidence of switch at 5 years was 21% (95% confidence interval, 20%-23%), with significant regional variations. Median time to switch was 30 (IQR, 16-58) months; two-thirds of switches were related to treatment failure. In multivariable analysis, older age, severe immunosuppression and higher viral load (VL) at ART start, and NVP-based initial regimens were associated with increased risk of switch. Conclusions: One in 5 children switched to a second-line regimen by 5 years of ART, with two-thirds failure related. Advanced HIV, older age, and NVP-based regimens were associated with increased risk of switch

Effects of biofouling on performance of moored data logging acoustic receivers

Biofouling on scientific equipment deployed in marine and estuarine environments can have implications for equipment performance, and the type and amount of data collected. We examined the effects of biofouling on the performance of data logging acoustic receivers deployed in shallow coastal waters off Florida. Five treatment types of receivers were examined including old and new versions of VR2 (Vemco Ltd) receivers with complete, partial, or no antifouling paint. Receivers were deployed for 2 mo, and acoustic signal detection rates examined. All receivers had some extent of biofouling during the course of the study, and performance was variable among treatment types. Old version receivers did not perform as well as new version receivers in all cases, and significant differences were apparent in detection rate and receiver performance metrics. Reductions in receiver performance over time occurred for most treatments and were likely due to settlement of biofouling organisms including barnacles, annelids, tunicates, and ascidians. Biofouling appeared to affect receiver performance over time and should be taken into account in acoustic telemetry studies